Connect
Anktiva and Pancreatic Cancer
A medication was recently approved by the FDA for bladder cancer. It was developed by ImmunityBio and Dr. Patrick Soon-Shiong. He's the same doctor and business leader that developed Abraxane. He was also a pancreatic surgeon early in his career. So he's the real deal.
The medication is called Anktiva. Though only approved for bladder cancer, there are a number of trials taking place for other cancers including pancan.
Does anyone have any personal experience with the medication and pancan? It sure seems like it could be the next-line therapy.
Thanks,
Like
Helpful
HugInterested in more discussions like this? Go to the Pancreatic Cancer Support Group.
Connect
@advavra After many false paths, we finally found the right office by working persistently with Kaiser's Patient Care group. However, after multiple denied applications and appeals, we failed to get Kaiser to approve any care or second opinions outside of Kaiser. We also hit dead ends with Immunity Bio, which were initially responsive, but then went dark. We finally decided to self-pay for testing and review at City of Hope. They recommended an MRI-guided radiation procedure, which comes with a few scary risks, and no way to know if it would extend her life a few weeks or a few months. None of the clinicians thought it would add more than a year. Also, to pay for the $300,000+ procedure, Mom would need to leave Kaiser and apply for traditional Medicare+Supplemental insurance. Ultimately, Mom, at 93 years of age, decided to stop seeking life-extending procedures. At this point, she is non-symptomatic and living her best life. She knows that this will eventually change and is at peace with that.
-
Like -
Helpful -
Hug
1 Reaction@rdmiller
Thank you. We're reviewing. Looks interesting.
@rdmiller The attached link goes to Amazon to purchase NK product. It does not go to the research. Can you please provide the research link? Thanks.
@tomrennie
Here's one with more to follow.
https://pubmed.ncbi.nlm.nih.gov/29939404/